Brent Stevenson, DO
Sleep Medicine · Frisco, TXNPI 1649204926
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,149 of the $9,299 with a category attached, or 66.1%. 17 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 36.1% of the total. 2025 is the largest year on record at $3,860, 8.4 times the $460 reported in 2019.
Across 249 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$3K
- Jazz Pharmaceuticals Inc.$3K
- Harmony Biosciences LLC$1K
- Avadel CNS Pharmaceuticals, LLC$531
- Inspire Medical Systems, Inc.$305
- ZOLL Respicardia, Inc.$235
- plus $818 from 11 others
What the payments were for
- Speaking & faculty fees$2,92531%
- Food & beverage$6,14966%
- Education$2252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $3,359 |
| Jazz Pharmaceuticals Inc. | 113 | $2,980 |
| Harmony Biosciences LLC | 55 | $1,072 |
| Avadel CNS Pharmaceuticals, LLC | 17 | $531 |
| Inspire Medical Systems, Inc. | 9 | $305 |
| ZOLL Respicardia, Inc. | 3 | $235 |
| Merck | 9 | $156 |
| Idorsia Pharmaceuticals US Inc | 8 | $143 |
| Fisher & Paykel Healthcare Inc | 4 | $127 |
| Itamar Medical Inc | 1 | $124 |
| Arbor Pharmaceuticals, Inc. | 5 | $88 |
| Azurity Pharmaceuticals, Inc. | 4 | $78 |
| 3b Medical, Inc. | 1 | $30 |
| Philips North America LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $16 |
| Apria Healthcare LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$3,025
- XYWAV$403
- Wakix$243
- LUMRYZ$235
- remede System$139
- WatchPATONE$124
How this compares
$9,299 in reported general payments places this provider in the 85th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 15 | $251,510 |
| BelsomraSuvorexant | 30 | $27,920 |
| Armodafinil | 27 | $2,887 |
| Gabapentin | 160 | $2,758 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 117 | $2,102 |
| Modafinil | 26 | $1,878 |
| Zaleplon | 36 | $1,127 |
| Doxepin Hcl | 26 | $950 |
| Clonazepam | 95 | $892 |
| Zolpidem Tartrate | 78 | $588 |
| Trazodone Hcl | 72 | $532 |
| Ropinirole Hcl | 11 | $451 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $375 |
| Mirtazapine | 12 | $304 |
| Lorazepam | 20 | $214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $156 | $27,92030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 112 sleep medicine providers in Texas.
Other sleep medicine in Frisco
- Vikas JainFrisco$673K
- Gerard MeskillSugar Land$1M
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.